Clinical Trial Update: Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating a cholesterol-lowering regimen combining bempedoic acid and ezetimibe (an ACL-inhibiting approach) in acute coronary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Syndrome
• Non-st-segment Elevation Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Bempedoic acid/ezetimibe combination

Snippet

Sponsor: Kaiser Permanente | Conditions: Cardiovascular Diseases, NSTEMI | Phase 4 | Status: UNKNOWN